0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Food & Water Human Health Effects Nanoplastics Sign in to save

Plastic in Arteries Tied With Higher Risk of Cardiovascular Problems

JAMA 2024 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 55 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Emily Harris

Summary

This report highlights research linking the presence of microplastics and nanoplastics in human arteries to a higher risk of cardiovascular problems. Evidence indicates that these tiny plastic particles have been found in common products like food containers, cosmetics, and drinking water, raising questions about their long-term effects on heart health.

Body Systems
Study Type Environmental

Past research has linked people’s exposure to microplastics and nanoplastics (MNPs) to health problems. MNPs have been found in a range of products, including food containers, cosmetics, and drinking water.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Microplastics, Nanoplastics and Heart Contamination: The Hidden Threat

This review examines growing evidence that micro- and nanoplastics can accumulate in human cardiovascular tissues, including blood, heart muscle, and arterial plaques. Researchers found that these particles may contribute to heart and blood vessel problems through inflammation, oxidative stress, blood clotting, and direct tissue injury. The study identifies plastic particles as a potential new environmental risk factor for cardiovascular health.

Article Tier 2

Microplastics and Nanoplastics in Atheromas and Cardiovascular Events

This landmark clinical study found that patients with micro- and nanoplastics detected in their carotid artery plaque had a significantly higher risk of heart attack, stroke, or death over a 34-month follow-up period compared to those without detectable plastics. This is one of the first studies to directly link microplastic presence in human blood vessels to worse cardiovascular outcomes. The findings suggest that plastic accumulation in arteries may be an important and previously unrecognized risk factor for heart disease.

Article Tier 2

Evidence, Mechanisms, and Clinical Implications of Microplastics and Nanoplastics As Emerging Cardiovascular Risk Factors: A Narrative Review

This review examines growing evidence that micro- and nanoplastics may contribute to cardiovascular health risks, with researchers having found these particles in human artery plaques and blood clots. Evidence indicates that the particles can enter the bloodstream, trigger inflammation, damage blood vessel walls, and potentially increase the risk of heart attacks and strokes. While the evidence is not yet conclusive, the study highlights an emerging area of concern that warrants further investigation into how everyday plastic exposure may affect heart and blood vessel health.

Article Tier 2

Tiny trouble: microplastics, nanoplastics, and their heartfelt impact on cardiovascular health

This review summarizes growing evidence that microplastics and nanoplastics have been found in human heart tissue, arterial plaques, and blood, and may increase the risk of cardiovascular disease. Lab studies show these particles can damage blood vessel walls, disrupt cholesterol processing, trigger inflammation, and promote blood clot formation, raising serious concerns about heart health.

Article Tier 2

Micro and Nano-plastic particles: What are they and do they effect cardiovascular health?

This review examines the cardiovascular health effects of micro- and nanoplastics, summarizing evidence that these particles have been detected in human tissues including arterial plaques and may promote endothelial dysfunction and inflammation. The authors call for further clinical and epidemiological research into cardiac risk.

Share this paper